Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for cognitive symptoms after electroconvulsive therapy in mood disorders
IRCT20190525043700N3Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of thiamine in confusion and affective disorder, sponsored by Babol University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
thiamine
03
Conditions
confusionaffective disorder
Beyond the preview
Go deeper on IRCT20190525043700N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190525043700N3.